Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02595710 · ClinicalTrials.gov registry record

Bartonella in Liver Transplant Patients

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
3
Enrollment target

NCT02595710: Completed study, sponsored by University of Minnesota.

NCT02595710 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02595710 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
3 participants
Enrollment target

Study Summary

Approximately 20 volunteers who have received a liver transplant and have been diagnosed with cryptogenic cirrhosis will be included in this study. Blood, skin and urine samples will be analyzed for Bartonella spp..

Interventions

  • OTHER Blood collection
  • OTHER skin punch biopsy collection
  • OTHER Urine sample collection

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2013-12
Est. Completion 2021-12-01
University of Minnesota

966 total trials

What the finished NCT02595710 record still lists

NCT02595710 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.

The record links to 0 conditions, and to 3 interventions - of which Blood collection is the first listed.

NCT02595710 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02595710 about?

NCT02595710 is a clinical study titled "Bartonella in Liver Transplant Patients". Approximately 20 volunteers who have received a liver transplant and have been diagnosed with cryptogenic cirrhosis will be included in this study. Blood, skin and urine samples will be analyzed for Bartonella spp..

What is the current status of trial NCT02595710?

This trial is currently completed. The enrollment target is 3 participants. The study started on 2013-12. Estimated completion is 2021-12-01.

What interventions are being tested in trial NCT02595710?

The interventions under investigation include: Blood collection (OTHER), skin punch biopsy collection (OTHER), Urine sample collection (OTHER).

Who is sponsoring clinical trial NCT02595710?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02595710, the US trial registry maintained by the National Library of Medicine. NCT02595710 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.